Effects of Combination Lipid Therapy on Coronary Stenosis Progression and Clinical Cardiovascular Events in Coronary Disease Patients With Metabolic Syndrome: A Combined Analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS)
- 1 December 2009
- journal article
- research article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 104 (11), 1457-1464
- https://doi.org/10.1016/j.amjcard.2009.07.035
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary AtherosclerosisJama-Journal Of The American Medical Association, 2007
- Simultaneous low-density lipoprotein-C lowering and high-density lipoprotein-C elevation for optimum cardiovascular disease prevention with various drug classes, and their combinations: a meta-analysis of 23 randomized lipid trialsCurrent Opinion in Lipidology, 2006
- Benefits of Niacin in Patients With Versus Without the Metabolic Syndrome and Healed Myocardial Infarction (from the Coronary Drug Project)The American Journal of Cardiology, 2006
- Diagnosis and Management of the Metabolic SyndromeCirculation, 2005
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)Jama-Journal Of The American Medical Association, 2001
- The Metabolic Syndrome, LDL Particle Size, and AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Niacin Decreases Removal of High-Density Lipoprotein Apolipoprotein A-I But Not Cholesterol Ester by Hep G2 CellsArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content.Heart, 1993
- Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein BThe New England Journal of Medicine, 1990
- Implications of findings in the coronary drug project for secondary prevention trials in coronary heart disease. The coronary; drug project research group.Circulation, 1981